"Science" Names HIV Prevention Trial As Breakthrough Of The Year Science named the HIV Prevention Trials Network (HPTN) 052 study "Breakthrough of the Year." FHI 360 congratulates our HPTN 052 collaborating partners on this important achievement. This is the second year in a row that Science selected a trial for which FHI 360 provided scientific leadership and operational support... 31 December 2011

Same-Sex Marriage Laws Reduce Doctor Visits And Health Care Costs For Gay Men Gay men are able to lead healthier, less stress-filled lives when states offer legal protections to same-sex couples, according to a new study examining the effects of the legalization of same-sex marriage in Massachusetts... 28 December 2011

Antiretrovirals Raise Birth Defect Risk HIV-positive mothers can protected their babies from becoming infected with the virus if they take antiretroviral drugs during pregnancy. However, even though these drugs prevent transmitting the disease to the child, they could potentially cause birth defects like cleft lip and palate... 27 January 2012

In HIV-Positive Patients, Standard Treatments For Head And Neck Cancer Are Less Effective Radiation therapy with or without chemotherapy is less effective for patients with HIV when compared to the recurrence and overall survival rates in patients who do not have HIV, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM. Treating head and neck cancer in HIV-positive patients is a challenge for oncologists... 27 January 2012

Pathogenic Landscape Of HIV In perhaps the most comprehensive survey of the inner workings of HIV, an international team of scientists led by researchers at the University of California, San Francisco has mapped every apparent physical interaction the virus makes with components of the human cells it infects work that may reveal new ways to design future HIV/AIDS drugs... 27 December 2011